Analyst firms · Wolfe Research · MET

Wolfe Research MET price target and rating history

MetLife Inc. (MET) · Finance

Wolfe Research rates MetLife Inc. (MET) Outperform with a $95 price target, as of its latest action on Sep 16, 2025. It has published 3 rating actions on MET since January 2022, including 1 upgrade and 0 downgrades. Across 3 firms with a MET price target in the last 12 months, the median target is $101.

Current rating
Outperform
Price target
$95
Median target, all firms
$101
Actions on MET
3

Wolfe Research price target on MET

$95$83$702023202420252026
Wolfe Research price target on MET, each point a stated target, January 2022 to September 2025.

Every Wolfe Research rating on MET

How other firms rate MET

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerOverweight$110Sep 22, 2026
Evercore ISIIn-line$97Jan 6, 2026
MizuhoOutperform$101Dec 16, 2025

Questions about Wolfe Research and MET

What is Wolfe Research's price target for MET?
Wolfe Research's latest stated price target for MetLife Inc. (MET) is $95, from its action on Sep 16, 2025.
What is Wolfe Research's rating on MET?
Wolfe Research rates MET Outperform, a bullish rating, as of Sep 16, 2025.
When did Wolfe Research last change its view on MET?
On Sep 16, 2025, Wolfe Research starts coverage at Outperform, price target $95.
How does Wolfe Research's MET target compare with other analysts?
Across 3 firms with a MET price target in the last 12 months, the median target is $101.

More MET rating histories

All Wolfe Research ratingsMET news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.